Financials

  • Market Capitalization 12.5 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-34.99
Fiyat/satışlar oranı
11.04

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
706
JAZZ
Jazz Pharmaceuticals plc - Ordinary Shares
239.01 USD+0.40%-2.34%+3.53%+70.72%15.00 B USD
740
EXEL
Exelixis, Inc. - Common Stock
55.83 USD+0.11%+0.76%+4.67%+43.01%14.03 B USD
820
SMMT
Summit Therapeutics Inc. - Common Stock
15.17 USD-1.94%-1.69%+7.44%-23.62%11.77 B USD
824
AXSM
Axsome Therapeutics, Inc. - Common Stock
233.84 USD-0.60%-5.19%-8.31%+79.60%12.03 B USD

Haberler